Endothelial Cell Killing by TAK1 Inhibition: A Novel Anti-Angiogenic Strategy in Cancer Therapy

Developmental Cell- United States

doi 10.1016/j.devcel.2019.01.011

Full Text

Abstract

Available in

Date

Authors

Publisher

Elsevier BV

Related search

Newly Developed Anti-Angiogenic Therapy in Non-Small Cell Lung Cancer

Oncotarget
Oncology
2017English

Selective Toxicity and Angiogenic Inhibition by Euglenophycin: A Role in Cancer Therapy?

Cancer Biology & Treatment
2016English

Inhibition of Experimental Choroidal Neovascularization by a Novel Peptide Derived From Calreticulin Anti-Angiogenic Domain

2018English

Alginate Hydrogel Improves Anti-Angiogenic Bevacizumab Activity in Cancer Therapy

European Journal of Pharmaceutics and Biopharmaceutics
MedicineBiotechnologyPharmaceutical Science
2017English

Integration of Pro- And Anti-Angiogenic Signals by Endothelial Cells

Journal of Cell Communication and Signaling
BiochemistryCell BiologyMolecular Biology
2017English

Cell Heterogeneity Revealed by On-Chip Angiogenic Endothelial Cell Migration

ACS Omega
ChemistryChemical Engineering
2020English

A Novel Anti-Vascular Therapy for Cancer

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2004English

Polo-Like Kinase 4 Inhibition: A Strategy for Cancer Therapy?

Cancer Cell
Cancer ResearchOncologyCell Biology
2014English

Anti-Angiogenic Therapy for Cancer: Current Progress, Unresolved Questions and Future Directions

Angiogenesis
Cancer ResearchClinical BiochemistryPhysiology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy